2016
DOI: 10.1016/j.ejca.2015.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
61
5
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 112 publications
(80 citation statements)
references
References 36 publications
2
61
5
2
Order By: Relevance
“…Advances in multidisciplinary management over the past decades have significantly increased the OS of adult sarcoma . In the present study, the 43 patients managed with a combination of surgical resection plus radiotherapy plus chemotherapy had a mean survival of 55 months versus 76 months for the 67 patients treated with surgery plus chemotherapy, 39 months for the eight patients treated with surgery plus radiotherapy, 69 months for the 29 patients treated with surgery alone and 13 months for the 25 patients treated without surgery.…”
Section: Discussionmentioning
confidence: 55%
“…Advances in multidisciplinary management over the past decades have significantly increased the OS of adult sarcoma . In the present study, the 43 patients managed with a combination of surgical resection plus radiotherapy plus chemotherapy had a mean survival of 55 months versus 76 months for the 67 patients treated with surgery plus chemotherapy, 39 months for the eight patients treated with surgery plus radiotherapy, 69 months for the 29 patients treated with surgery alone and 13 months for the 25 patients treated without surgery.…”
Section: Discussionmentioning
confidence: 55%
“…The features favouring morphological responders included fibrosis, necrosis, cholesterol clefts, haemosiderin‐laden macrophages, foamy histiocytes, inflammation, cytoplasmic degeneration, pleomorphism, bizarre nuclei, and tumour architecture . Similarly, in soft tissue and bone sarcomas, the NAC effect was assessed by evaluating the percentage of the area of tumour response relative to that of the residual tumour; patients who showed good response showed better survival . Although necrosis was long regarded as the only morphological evidence of tumour response, foamy or haemosiderin‐laden macrophages, fibrosis and smudgy chromatin were recently added as features indicative of response that should be incorporated in the evaluation of the NAC effect in soft tissue and bone sarcomas .…”
Section: Discussionmentioning
confidence: 99%
“…Criteria for inclusion were: measurable tumor with MRI, available MRI performed <28 days before the first cycle of NAC (baseline, MRI_0) and between cycles 2 and 3 of NAC (early evaluation, MRI_1), 4 to 6 cycles of NAC, and histological response assessment on surgical specimen by an expert pathologist following published guidelines . A threshold of <10% of viable cells assessed on whole tumor defined good histological response (good‐HR) …”
Section: Methodsmentioning
confidence: 99%